Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Aeolus receives U.S. government contract to develop AEOL-10150 for lung ARS

Feb. 17, 2011

Genotype of polymorphic SLC6A4 gene variants modulates effects of cocaine in vitro

Feb. 16, 2011

Nicotinic acetylcholine alpha5 receptor may represent new target of smoking cessation therapies

Feb. 8, 2011

DigiFab approved in Canada to treat digoxin toxicity/overdose

Feb. 1, 2011

CBLB-502 demonstrates direct anticancer effect in preclinical models

Jan. 24, 2011

RiVax receives FDA orphan drug status for prevention of ricin intoxication

Jan. 24, 2011

Histamine H3 receptor antagonist JNJ-39220675 shows promise against alcoholism

Jan. 21, 2011

FDA approves new formulation of acetylcysteine injection

Jan. 18, 2011

New cannabinoid CB1 receptor antagonists presented by sanofi-aventis

Jan. 13, 2011

Anticocaine vaccine dAd5GNC shows promise in mice

Jan. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...